Supplement to: McClellan M. Drug Safety Reform at the FDA — Pendulum Swing or Systematic Improvement? N Engl J Med 2007;356(17):1700-2. DOI: 10.1056/NEJMp078057.

Mark McClellan is a visiting senior fellow at the AEI–Brookings Joint Center for Regulatory Studies, Washington, DC, and is on leave as an associate professor of economics and medicine at Stanford University, Stanford, CA. Dr. McClellan was commissioner of the FDA from November 2002 to March 2004.

Jerry Avorn is a professor of medicine at Harvard Medical School and chief of the Division of Pharmacoepidemiology and Pharmaeconomics at Brigham and Women’s Hospital in Boston.

Rachel Gotbaum, the interviewer, is an independent producer based in Boston.

• Download Interview MP3 (10:24, 4.7 MB)
•   Subscribe to Podcast
• Listen to Other Interviews